Inc. designs, tests and licenses bioactive coatings for medical applications. The Company incorporates a variety of classes of active agents into coatings: antimicrobial, analgesic, anti-thrombotic, anti-inflammatory, and other drugs suitable for medical applications. Bacterin also produces and markets innovative biologic alografts for transplantation. The Company's products, OsteoSponge®, OsteoSpongeSC® and OsteoWrap™, are made from demineralized bone that is malleable and flexible, which enables more efficient and precise handling. It also markets OsteoLock®, used in spine surgery, minimizes graft back-out, and increases osteoinductivity. Headquartered in
Belgrade, Montana, Bacterin operates a 32,000 sq. ft., state-of-the-art, full compliant and FDA registered facility, equipped with five Class 100 clean rooms.
This news release contains disclosures that are forward-looking statements. Forward-looking statements include statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as "continue," "efforts," "expects," "anticipates," "intends," "plans," "believes," "estimates," "projects," "forecasts," "strategy," "will," "goal," "target," "prospects," "potential," "optimistic," "confident," "likely," "probable" or similar expressions. These forward-looking statements are based on current expectations or beliefs and include, but are not limited to, statements about maximizing gross profit dollars, the Company's potential to achieve top and bottom line growth. Statements of historical fact also may be deemed to be forward-looking statements. We caution that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others: the company's ability to meet its obligations under existing and anticipated contract
'/>"/>
SOURCE Bacterin International, Inc. Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine technology :1.
International Merchant Advisors, Inc. Offers to Invest in Pharmaceutical Chain2.
DATATRAK International and PFC Pharma Focus to Co-Sponsor eClinical Solutions Seminar in Tel Aviv3.
CORD:USE Cord Blood Bank Featured Internationally on CNN en Espanol4.
Mettler-Toledo International Inc. Reports Fourth Quarter 2009 Results5.
Cayman Island National Insurance Company Reaches Service Agreement with Mobile Surgery International6.
The International Negative Pressure Wound Therapy Expert Panel to Announce Results of Inaugural Symposium in Hamburg7.
International NPWT Expert Panel Convenes in Hamburg8.
Chindex International to Report Third Quarter Fiscal Year 2010 Financial Results9.
PRA International Formalizes Partnership with Oncopartners and IBPC10.
DATATRAK International, Inc. Announces Year-End Backlog11.
International Drug & Explosives Detection Firm IDenta Corp Announces that the TNT/PETN/RDX/NITRATE Test Kit can be used as a General Screening Explosive Identifier